Is it a good or bad time for a health-tech company to raise?
This is a co-written piece with HTN’s Ryan Russell and Kevin O’Leary
TL;DR: With the overall market going bananas and a potential recession looming, there is a lot of speculation on the impact to the private health tech market. So we, HTN and OMERS Ventures, have teamed up to survey ~150 health care startup operators and investors for perspectives on changing conditions. Some of these observations may seem obvious to many of you, but we saw a need for a more quantitative (admittedly unscientific) analysis. And we made the survey anonymous, so recipients could speak their minds.
Here were some takeaways that we’ll dive deeper into below:
About the author
Christina Farr
Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.
New York City